We have identified two families with a previously undescribed lethal X-linked disorder of infancy; the disorder comprises a distinct combination of an aged appearance, craniofacial anomalies, hypotonia, global developmental delays, cryptorchidism, and cardiac arrhythmias. Using X chromosome exon sequencing and a recently developed probabilistic algorithm aimed at discovering diseasecausing variants, we identified in one family a c.109T>C (p.Ser37Pro) variant in NAA10, a gene encoding the catalytic subunit of the major human N-terminal acetyltransferase (NAT). A parallel effort on a second unrelated family converged on the same variant. The absence of this variant in controls, the amino acid conservation of this region of the protein, the predicted disruptive change, and the co-occurrence in two unrelated families with the same rare disorder suggest that this is the pathogenic mutation. We confirmed this by demonstrating a significantly impaired biochemical activity of the mutant hNaa10p, and from this we conclude that a reduction in acetylation by hNaa10p causes this disease. Here we provide evidence of a human genetic disorder resulting from direct impairment of N-terminal acetylation, one of the most common protein modifications in humans.
Introduction
Researchers have used exon capture and high-throughput sequencing (exome sequencing) to identify the molecular etiology of several Mendelian disorders. [1] [2] [3] [4] [5] It has been used in studies of a multigenerational pedigree 6 and a de novo disorder, 1 and it has been applied in molecular diagnostics. 7 Most of these efforts have focused on characterizing previously described and recognizable genetic syndromes, such as Kabuki (MIM 147920), 1 Miller (MIM 263750), 2, 8 and TARP (MIM 311900) 9 syndromes. These efforts to search for the molecular etiology of known syndromes benefited from years of clinical evaluations, allowing researchers to combine unrelated individuals in the same cohort for analysis. In contrast, exon capture and sequencing can help to identify previously unrecognized syndromes. We have characterized such a syndrome, in which the afflicted boys have an aged appearance, craniofacial anomalies, hypotonia, global developmental delays, cryptorchidism, and cardiac arrhythmias. To determine the genetic basis of this syndrome, we used X chromosome exon capture and sequencing and a recently developed probabilistic algorithm aimed at discovering disease-causing variants. We also demonstrate that this phenotype results from a decrease in the function of an enzyme involved in N-terminal acetylation of proteins.
Subjects and Methods
We describe two parallel genetic research efforts that converged on the same gene variant. The two groups working on this project became aware of each other's work after the genetic analyses had been completed, and therefore the methodologies used varied somewhat. When these methods differed, they are described separately.
The sample collection and analyses of families 1 and 2 were approved by the institutional review boards at the University of Utah and the National Human Genome Research Institute, respectively. Written informed consent was obtained from the parents of affected children for collected blood samples and extracting DNA from stored samples. Blood samples were collected and genomic DNA extracted with alkaline lysis and ethanol precipitation (Gentra Puregene, QIAGEN, USA). Two DNA samples from family 1 were extracted from stored formalin-fixed-paraffinembedded (FFPE) tissues from the prior autopsies of two of the deceased boys. Slices from FFPE tissue blocks were digested overnight in proteinase K and then boiled for 10 min to inactivate the enzyme. The crude lysates were diluted 1:10 for PCR.
Genomic Microarrays and Copy-Number Variation Analysis
Copy-number variation in individual III-4 in family 1 was evaluated with two oligonucleotide-based genomic microarray platforms, the U-array Cyto6000 (manufactured by Agilent Technologies, Santa Clara, CA) and the SignatureChip Oligo Solution microarray (manufactured by Roche NimbleGen). Both platforms use a custom design with approximately 10 kb coverage for many clinically relevant syndromes and telomere and pericentromeric regions,; the genome-wide coverage is 75 kb for the U-array and 35 kb for the SignatureChipOS. The U-array data were analyzed with DNA Analytics 4.0.76 software from Agilent Technologies with the ADM-1 algorithm. The SignatureChipOS data were analyzed with Genoglyphix software (Signature Genomics, Spokane, WA).
X-Chromosome Exon Capture and Sequencing
Exon capture for family 1 was carried out with a commercially available Agilent in-solution method (SureSelect Human X chromosome kit, Agilent) as per the manufacturer guidelines with minor modifications. Randomly fragmenting the pure and highmolecular-weight genomic DNA samples with a Covaris S series Adaptive Focused Acoustics machine resulted in DNA fragments with a base pair peak of 150 to 200 bps. Adaptors were then ligated to both ends of the resulting fragments. The adaptor-ligated templates were purified by the Agencourt AMPure SPRI beads. Adaptor-ligated products were amplified by PCR with Phusion polymerase (six cycles) and subsequently purified with a QIAGEN QIAquick PCR purification kit. The quality and size distribution of the amplified product was assessed on an Agilent Bioanalyzer DNA 1000 chip. Amplified library (500 ng) with a size range of 200-400 bp was hybridized to SureSelect Biotinylated RNA Library (BAITS) for enrichment. Hybridized fragments were bound to the strepavidin beads whereas nonhybridized fragments were washed out after a 24 hr hybridization. The captured library was enriched by amplification by PCR (12 cycles), and the amplified product was subsequently qualified on an Agilent High Sensitivity DNA Bioanalyzer chip to verify the size range and quantity of the enriched library. Each captured library was sequenced with 76 bp single-end reads on one lane each of the Illumina GAIIx platform. Raw image files were processed by Illumina Pipeline v1.6 for base-calling with default parameters. All coordinates are based on the human genome build hg18. The pseudoautosomal regions were defined based on annotations within the UCSC genome browser. Specifically, these are the regions chrX:1-2709520, chrX:154584238-154913754, chrY:1-2709520, and chrY:57443438-57772954. For family 2, solution hybridization selection of the X exome (Sure Select, Agilent, Santa Clara, CA) was used to produce a paired-end sequencing library (Illumina, San Diego, CA) as previously described. 9 Paired-end 75 bp reads were generated from the target-selected DNA library in one lane of an Illumina GAIIx. Coding changes were predicted with custom-designed software.
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Sanger Sequence-Confirmation Analysis
Amplification by PCR and Sanger sequencing were performed as described so that mutations and the cosegregation could be confirmed. 10 Mutation numbering was performed according to Human Gene Variation Society nomenclature with reference NM_003491.2.
Sequence Alignment
For family 1, sequence reads were converted from Illumina fastq format to fastq files that conform to the Sanger specification for base-quality encoding with perl scripts. Burroughs Wheeler alignment (BWA) 11 version 0.5.8 was used to align the sequencing reads, and the default parameters were used for fragment reads, to the human genome sequence build 36 downloaded from the UCSC Genome Browser or the 1000 Genomes Project websites.
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Alignments were converted from SAM format to sorted, indexed BAM files with SamTools. 13 The picard tool was used to remove invalid alignments and remove duplicate reads from the BAM files.
Regions surrounding potential indels were realigned with the GATK IndelRealigner tool. 14 Variants were called with SamTools pileup command with the default parameters except that no upper limit was placed on the depth of coverage for calling variants. In addition, haploid chromosomes were called with the -N 1 options SamTools pileup. Variants were annotated with respect to their impact on coding features with perl scripts and the knownGenes and RefGenes tracks from the UCSC Genome Browser. 15 
Genotype Calling
Regions surrounding potential indels were realigned with the GATK IndelRealigner tool. 14 Genotypes were called with both SamTools (pileup command) and the GATK UnifiedGenotypeCaller and IndelCaller. 14 We then analyzed the union of single nucleotide variant (SNV) and indel variant calls from GATK and SamTools with the ANNOVAR program 16 to identify exonic variants and to identify variants not previously reported in the 1000 Genomes Project and the dbSNP version 130. All variant calls not present on the X chromosome were removed given the X-linked nature of the disease. We analyzed the location and genotype of variants for each individual to locate the subset of variants on the X chromosome that were heterozygous in female carriers, hemizygous in individual III-4, and a hemizygous reference in the unaffected males. Each candidate variant was also screened for presence or absence in dbSNP 130, 17 the 10Gen Dataset 18 and variant data from the 1000 Genomes Project. 12 We also used the read-mapping and SNV-calling algorithmGNUMAP 19 independently to align the reads from the Illumina.qseq files to the X chromosome (human sequence build 36) and to simultaneously call SNVs. GNUMAP utilizes a probabilistic pair-hidden Markov model (PHMM) for base calling and SNV detection that incorporates base uncertainty on the basis of the quality scores from the sequencing run, as well as mapping uncertainty from multiple optimal and suboptimal alignments of the read to a given location to the genome. In addition, this approach applies a likelihood ratio test that provides researchers with straightforward SNV-calling cutoffs based on a p value cutoff or a false discovery control. Reads were aligned and SNVs called for the five samples. SNV calls for individual III-4, his brother, and his uncle were made assuming a haploid genome (because the calls are on the X chromosome), whereas heterozygous calls were allowed for the mother and grandmother. SNVs were selected based on a p value cutoff of 0.001. Because of the X-linked nature of the disease, candidate SNVs were selected that are heterozygous in the mother and grandmother and different between the uncle and brother and individual III-4.
Variant Annotation, Analysis, and Selection Tool Analysis
The SNV filtering was performed with the simple selection tool (SST) module in variant annotation, analysis, and selection tool (VAAST) on the basis of on the SNV position. Our analysis applied a disease model that did not require complete penetrance or locus homogeneity. We restricted the expected allele frequency of putative disease-causing variants within the control genomes to 0.1% or lower. 
Short-Tandem-Repeat Genotyping
Genotyping on family 1 was performed on DNA extracted from peripheral blood or FFPE tissues with a panel of 16 polymorphic short-tandem-repeat (STR) genotyping markers spanning the long arm of chromosome X (Applied Biosystems Linkage Mapping Set v2.5-MD10 and custom primers DXS8020, DXS1275, DXS6799, DXS1203, DXS8076, and DXS8037). Fluorescently labeled PCR products were separated with an Applied Biosystems 3130XL Genetic Analyzer and analyzed with GeneMapper Software version 3.7. Genotyping and haplotype analysis for family 2 was performed for a subset of markers on the X chromosome (DXS9900, DXS9896, DXS8016, DXS1003, DXS2132, DXS990, DXS6797, DXS8057, GATA31E08, DXS7127, and DXS1073) as described. 21 
Analysis of Haplotype Sharing
Using GNUMAP software and the X chromosome exon sequence data from family 1, we derived 1322 polymorphic markers on the mother's X chromosomes. We then determined the regions shared or not shared by individual III-4 and his unaffected brother.
Screening for Frequency of Causal Variants
We manually screened for the presence or absence of c. 
Sorting Intolerant From Tolerant Analysis
The sorting intolerant from tolerant (SIFT) sequence was used with the sequence of hNaa10p (NP_003482) as input. The following parameters were used: the database searched was the UniProt-SwissProt þ TrEMBL 2010_09 and the median conservation of sequences was 3.00 (between 0 and 4.32, between 2.75 and 3.25 is recommended). The substitution at position 37 from S to P was predicted to affect protein function with a score of 0.00. In the assays investigating the N-terminal acetyltransferase activity toward selected substrate peptides, purified MBP-hNaa10p WT or p.Ser37Pro were mixed with oligopeptides, acetyl-CoA and acetylation buffer. After incubation at 37 C, the acetylation reaction products were quantified with RP-HPLC as described previously. 11, 13 In the assays investigating the N-terminal acetyltransferase activity toward the acidic N termini of actins (DDDIA or EEEIA), 15 nM of purified MBP-hNaa10p WT or S37P were mixed with 250 mM of oligopeptides. In the assays where the AVFAD and SESSS based oligopeptides were tested, 250 nM of purified enzyme were mixed with 200 mM of mentioned oligopeptides. All samples were further mixed with 400 mM acetyl-CoA and acetylation buffer (1 mM DTT, 50 mM Tris-HCl [pH 8.5], 800 uM EDTA, 10% glycerol) in a total volume of 100 ml. The samples with actin-based oligopeptides as substrates were incubated at 37 C for 15 min, whereas the SESSS and AVFAD reactions were incubated at 37 C for 20 min. In the time-course acetylation experiments, the same conditions as mentioned above were used, and samples were collected at indicated times. For all aliquots collected, the enzyme activities were quenched by adding 5 ml of 10% TFA.
The acetylation reaction products were quantified with RP-HPLC as described previously. 11 All peptides were custom-made (Biogenes) to a purity of 80%-95%. All peptides (24- 
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th centile); flared nares; a short columella; a short philtrum with an overhanging upper lip; a thin vermillion border of the lips; a narrow palate; microretrognathia; an umbilical hernia; small, ''high riding'' testes; long fingers; fullness to the dorsum of the feet; metatarsus valgus; capillary malformation over the glabella, eyelids, philtrum, and nape of neck; and hypertonia. Diagnostic studies had included karyotype analysis (46, XY), very long-chain fatty acids (normal), glycerine kinase (normal), total carnitine (slightly elevated), urine organic acids (normal), biotinidase activity (normal), an EKG that was somewhat irregular, and a CT scan of the head demonstrating cerebral atrophy versus dysgenesis. At 9 1 / 2 months of age, he died after presenting to the hospital with multiple apneic episodes.
Individual III-7 was born at 33 weeks of gestation to a 21-yearold G 1 P 0/1 , reported as having gestational diabetes; he was delivered by elective C-section because of concern that he suffered from polycystic kidneys, oligohydramnios, and pulmonary hypoplasia. His birth weight was 1559 g, (10 th 
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th centile), and he had a length of 39 cm, (10 th centile); his OFC was 27 cm, (3 th À10 th centile), and his Apgar scores were 4 1 and 8. 5 He was noted to have distinctive facial features and a large anterior fontanel and right-sided cryptorchidism and inguinal hernia. His newborn course was complicated by polycythemia, jaundice, low cortisol, and mild pulmonary hypoplasia. He spent approximately 5 weeks in the neonatal intensive care unit (NICU); he required assisted ventilation for 3 days with the rest of the time dedicated to feeding and growing. Diagnostic studies conducted during the neonatal period included renal ultrasonography (which was normal) and echocardiography, demonstrating a small persistent ductus arteriosus, a mildly decreased left ventricular systolic function, an abnormal appearing aortic valve, and an enlargement of the right ventricle, decreased right ventricular systolic function, and persistence of the foramen ovale. At 5 1 / 2 months of age, he was in his usual state of health until 2 days prior to admission, when he developed rhinorrhea; one day prior to admission he developed a fever. He presented to the hospital with increased irritability. At first he did not appear very ill, but he quickly progressed to shock and death.
At the autopsy he was noted to have a congenital hypotonialymphedema sequence; hypertelorism; a high, broad forehead with a frontal furrow; micrognathia; cardiomegaly (the right half of the heart was greater than left) and the persistence of the foramen ovale; adrenomegaly; and bilateral enlarged kidneys; and abnormal development, including fetal lobulations, glomerulocystic change, sclerotic glomeruli, micronodular distal tubule proliferation, hypoplastic or small testes, a right-sided inguinal hernia, and right-sided cryptorchidism.
Individual III-4 ( Figures 1 and 2B ) was born at 37 3 downslanting palpebral fissures, long eyelashes, a bifid and depressed nasal tip, prominent nares, prominent ears, a short neck with excess nuchal skin, torticollis, pectus excavatum, scoliosis, and a small scrotal sack with left cryptorchidism. He had been able to build up subcutaneous fat stores, presumably because of G tube feeding,. He developed a very thick, dark head of hair by his first birthday. Diagnostic studies had included urine organic acids (normal); serum immunoglobulins (normal); comparative genomic hybridization U-array 44 k platform (normal); and an MRI of the brain with spectroscopy that demonstrated bilateral symmetric globus pallidus T2 prolongation without diffusion restriction, a nonspecific elevation of choline and prominence of the Sylvian fissures, immature myelination of the splenium, and moderate lateral and third ventricular dilation without identified cause. An MRI of the spine demonstrated convex-right curvature reflecting compensation for moderately severe convex right C-shaped thoracic neuromuscular scoliosis without any noted congenital vertebral segmentation anomalies. These pictures demonstrate the prominence of eyes, down-slanted palpebral fissures, thickened lids, large ears, flared nares, hypoplastic alae, short columella, protruding upper lip, and microretrognathia.
He had renal ultrasonography (normal), and echocardiography demonstrated a small perimembranous ventricular septal defect (VSD), patent foramen ovale or small secundum atrial septal defect, a mild left atrial enlargement, a trivial pulmonary stenosis, and a trivial bilateral branch pulmonary artery stenosis. Cranial radiography demonstrated a small sella turcica. Holter monitoring and the EKG had been entirely normal, but he eventually developed a nonspecific T-wave abnormality.
He died at 15 months of age after a protracted hospitalization during which he originally presented with multiple hypoxic episodes. He had a surgical correction of his severe scoliosis to optimize his pulmonary function. He developed a bradyarrhythmia and hypoxia and eventual pulseless electrical activity. After then suffering a full arrest and resuscitation, he was supported by mechanical ventilation until his parents chose to withdraw support.
An extensive autopsy of individual III-4 revealed multiple minor external anomalies, severe scoliosis, an enlarged heart with a form fruste of a perimembranous VSD, and several findings that could be attributed to hypoxia and ischemia during individual III-4's terminal course, including slight waviness of myocardial fibers (early ischemic change), pulmonary congestion and intra-alveolar edema, serous effusions in all body cavities, mid-to central zone hepatocytic necrosis, and acute neuronal ischemia in the brain. Focal segmental and global glomerulosclerosis in the outer renal cortex suggested a more chronic or remote injury that might or might not be related to the underlying genetic disorder, but no other histologic or ultrastructural lesion was identified.
Individual was performed, and he was placed in a half-body cast. On the evening after the procedure, he apparently aspirated and had a respiratory arrest, and then had generalized seizures and an apparent posthypoxia encephalopathy. He recovered from this and was discharged but died at home several days later. In 2005, individual III-2 ( Figure 2D ) was born at 39.7 weeks of gestation to a 25 year-old primigravida. The pregnancy was complicated by fetal supraventricular tachycardia, which occurred at 20 weeks of gestation and was controlled with maternal administration of flecainide. hernias. The first and second toes appeared widely spaced. His karyotype was normal (500 bands). His copper and ceruloplasmin levels were low, but his plasma catecholamine levels were normal, ruling out Menkes syndrome (MIM 309400 He experienced three tonic-clonic seizures, and there was decerebrate posturing during the last. After loading with phenobarbital was performed, no further seizures occurred, and he returned to baseline. He continued to have excessive stool output, but electrolyte levels remained normal. He experienced increased difficulty in breathing and poor perfusion and was transferred to the prenatal intensive care unit, where he had a wide complex rhythm at 120-140 beats per minute. Ultimately, the rhythm became irregular, pulses were not palpable, and attempts to resuscitate him were unsuccessful. The autopsy showed severe micro-and macrovesicular steatosis. Because of the prenatal SVT and the rhythm disturbance without any causal electrolyte disturbance at the end of his life, his heart was evaluated postmortem for abnormalities of the conduction system. This analysis showed focal subendocardial scarring, but no cardiomyopathy or conduction system abnormalities were found. Rare inflammatory infiltrates suggested the possibility of a resolved infection. In 2007, individual III-4 ( Figure 2D ) was born at 34 weeks of gestation to his 24-year-old mother, who had a 3-year-old daughter at the time. At 6.5 months of age, he had an episode of aspiration, after which gastrostomy and a tracheostomytubes were placed. At the age of 15 months, he was hospitalized for 5 weeks for an infection. The family was told a defibrillator was needed and surgery was done for this. Two days after his discharge, he died at home at the age of 16 months.
Results

Family 1
Individuals II-1 and II-6 from family 1 ( Figure 1 and Figure 2 ) presented in the mid-1980s to the University of Utah Medical Center. These boys had striking similarity to each other with an array of shared manifestations (Table 1) . Both subsequently died in infancy. At that time no specific diagnosis could be made, and the inheritance pattern was uncertain, though autosomal-recessive and X-linked inheritance modes were considered. X-linked inheritance was confirmed in the next generation, when individuals III-4 ( Figure 1 ) and III-7 (Figure 2A) presented. The aged appearance was the most striking part of the disease.
Family 1 X-Chromosome Exon Capture and Sequencing
Two genomic microarray analyses in individual III-4 did not show any likely causal copy-number variants. Accordingly, X chromosome exon capture and sequencing were used to screen for variants within coding regions. We established the following filtering criteria for five samples to determine the final set of variant calls: variants must be present on the X chromosome in individual III-4 (hemizygous), heterozygous in individual II-2 (the mother), heterozygous in individual I-2 (the grandmother), and absent in individuals III-2 and II-8 (the unaffected brother and unaffected uncle). Table 2 shows the coverage statistics of the X chromosome exon capture. The exon sequencing reads were processed by three independent variant-calling pipelines to increase the accuracy for SNVs and/or microindels (Table 3) . These three variantcalling pipelines converged on a small list of candidate variants, which were annotated by ANNOVAR 16 for functional importance. One mutation had not been seen previously in dbSNP or the 1000 Genomes Project database. It is missense mutation c.109T>C in NAA10, which predicts p.Ser37Pro (MIM 300013) and was confirmed by Sanger sequencing ( Figure 2C ). We confirmed that this mutation was not present in 401 participants (90% white and mixed European descent and 96% nonlatino) in the ClinSeq project 22 nor was it seen in a combination of 6000 genomes or exomes (the majority of white and mixed European descent) collected in ongoing projects at Children's Hospital of Philadelpha, University of Utah, and/or BGI.
VAAST Analysis
We also used a recently developed tool (VAAST), 23 which identifies disease-causing variants, to analyze the exon capture data from family 1. VAAST annotates the SNVs on the basis of their effect on coding sequences, selects the variants compatible with the pedigree, and performs a statistical analysis on the X chromosome genes to identify the variant(s) most likely to be disease-causing. In the candidate-gene identification step, VAAST uses a likelihood ratio test that incorporates both amino acid substitution frequencies and allele frequencies to prioritize candidate genes on the basis of SNVs present in those genes. The analyses by VAAST of the variant sets generated from the three variant-calling pipelines yielded similar results and identified the same causal mutation in NAA10. With SNVs from the affected child (individual III-4) alone, VAAST was able to narrow the candidate-gene list to fewer than five genes (Table 4) . We then filtered the data by only selecting SNVs shared by the mother (individual II-2) and the affected child (individual III-4). This subset resulted in three, two, and two candidate genes in the GATK, Samtools, and GNUMAP datasets, respectively (Table 4) . Next, we filtered the data by selecting SNVs shared by the mother (individual II-2), the maternal grandmother (individual I-2), and the affected child (individual III-4). This subset resulted in two, two, and one hits in the three datasets, respectively, and NAA10 ranked first in all three lists. When we further excluded the SNVs that were present in the unaffected brother and uncle, VAAST identified a single candidate disease-causing variant in NAA10 in the GATK and the Samtools datasets and two candidate diseasecausing variants in NAA10 and RENBP in the GNUMAP dataset (Table 4) .
Confirmation in Other Family Members
DNA samples from other members of family 1 were obtained from the medical examiner; the samples include VAAST candidate genes (NAA10 ranking) DNA isolated from FFPE tissues from two of the deceased boys. Sanger sequencing in 14 DNA samples derived from blood or FFPE tissue from the family confirmed that the mutation in NAA10 cosegregated according to the deduced affection status or carrier status in all members of the family (Figure 2A and Figures S1-S5 , available online). During the course of this work, another boy (individual III-6) was born to individual II-3 in family 1 ( Figure S6 ). This boy was clinically diagnosed as having the syndrome and also was confirmed to have the mutation by Sanger sequencing.
Haplotype Analysis
Having identified a putative causative mutation from the X chromosome exon analysis, we performed haplotype analysis on family 1 to exclude regions of the X chromosome from which we could have possibly missed a mutation because of a lack of exon capture or a lack of sequencing coverage. We performed haplotype analysis by using two data sets: (1) (Table 5 and Table S1 ). The sequencing data showed that of the~155 Mb on the X chromosome, the affected brother (III-4) and unaffected brother (III-2) were identical at~71% and were recombinant at only 29%. Thẽ 14 Mb region is located on the telomeric end of the long arm of the X chromosome and includes NAA10. Subsequent addition of STR genotyping from the newborn affected male (III-6) further narrowed this interval to chrX:143,836,276-154,913,754 (telomere) (~11 Mb), which still includes NAA10 (Table 5 ). Coverage Analysis Exon capture techniques cannot capture all exonic regions because of design issues with replicative regions; this can therefore result in an incomplete set of variants. The X chromosome Agilent design consists of over 3 Mb of exon intervals. We evaluated the capture and sequencing coverage for all the currently known 1959 chrX transcripts in RefSeq (hg18). On the X chromosome, there are 8222 unique RefSeq exons. Of these exons, 736 were excluded from the SureSelect X-Chromosome Capture Kit because they were designated as pseudoautosomal or repetitive sequences (UCSC Genome Browser). The remaining 7486 exons have an average length of 358.9 bases and are covered on average by 5.7 bait probes per exon (bait probes were 120 bases long). The average read coverage in these regions was 214.6 reads per base; in these regions an average of 97.8% of the bases were covered by one or more reads, and 95.6% were covered at 103 or better. We also analyzed the average coverage for each gene (calculated as the total read bases within exons divided by the exon length) more specifically in the affected haplotype in the 14 Mb critical region derived from analysis of family 1 (Table S2 ). The average coverage was 1853 among the 167 nonpseudoautosomal or duplicative RefSeq transcripts (110 unique genes) in the 14 Mb region. These 167 transcripts consist of 864 exons, of which 860 had some read coverage and 809 had reads covering more than 95% of the bases in the exon. Most of the exon portions in the 14 Mb region that were not covered by reads were from the 89 exons not included in the SureSelect X-Chromosome Capture Kit because they were in the pseudoautosomal or duplicative regions. There was some coverage on a handful of these exons as well as intronic and intergenic regions flanking covered exons as a consequence of the experimental protocol. For example, if an excluded exon or intronic sequence is close (~500 bases) to an exon that is captured, the long fragment size (and the fact that we only sequence the end of the fragment) can lead to reads for the exon or intron. In the NAA10 haplotype region, we had greater than 103 coverage for 86% of the exons in the region for family 1; the corollary of this means that 97 exons do not have 103 coverage in the NAA10 region. However, of the 856 exons in the 14 Mb region that did have >103 coverage, the GNUMAP and VAAST approach found only two candidate SNVs that met our criteria (present in proband, not present in his brother and uncle, polymorphic in his mother and grandmother, nonsynonymous, not in the 1000 genomes or dbSNP), and in the exons in the 30 Mb region, no SNVs met our criteria. Theoretically, we could have nonetheless missed a crucially important variant, so we needed to use parallel approaches to prove causality of the variant in NAA10.
A Second Family
During preparation of a manuscript reporting the above results, another group (L.M.B., J.J.J, L.G.B.) communicated to us that they had also identified the NAA10 c.109T>C mutation in an apparently unrelated family (herein designated as family 2) with an indistinguishable phenotype (see Figure 2D and 2E). Haplotype analysis had been performed for family 2, and it identified a shared region of chrX:140,061,918-154,913,754 (~14 Mb) in three carrier females (I-2, II-2, and II-3) that was not present in an unaffected male (III-5). The borders of the region were defined by recombinant marker GATA31E08 and the q terminus.
Massively parallel sequencing of X chromosome exons was done on DNA samples from an obligate carrier and her unaffected child as previously described. 9 The entire X chromosome exon region target sequence was 2,784,426 bp, and the X chromosome exon region oligonucleotide library was designed to target 2,264,175 bp of this (81.3% The genotypes were filtered on the basis of several attributes that were felt to be appropriate for this disorder (Table 6 ). Heterozygosity was used because the test subject was an unaffected female carrier for an X-linked trait. We performed further filtering to include nonsynonymous, splice-site, frame-shifting, and nonsense variants. Filtering to exclude variants present in dbSNP or in the ClinSeq cohort (401 control individuals) 22 was also performed.
Finally, a filter that bounded the variants genomically within the shared 14 Mb haplotype region was applied. This left one variant, a single missense mutation, c.109T>C in NAA10. This variant was confirmed in the other individuals, and mutation status segregated with affection status and carrier status ( Figure 2D ).
Genome-wide Significance
We next assessed whether adding members of family 2 would improve the power of the VAAST analysis. We combined variants from individual III-4 in family 1 with the obligate carrier mother (II-2) in family 2 and performed VAAST analysis on the 216 coding SNVs present in either of the two individuals. After incorporating the mother from family 2, NAA10 was the only candidate gene, and the result was statistically significant (p value ¼ 3.8 3 10 À5 ;
Bonferroni corrected p value ¼ 3.8 3 10 À5 3 729 ¼ 0.028).
Lack of Relatedness of the Two Families
Both families are of mixed European ancestry. To evaluate whether the two families inherited the NAA10 variant from a recent shared founder, we examined SNVs surrounding this variant to test for evidence of identityby-descent (IBD). Assuming no sequencing errors, the largest region consistent with IBD between the two probands is only 30 kb (Table 7) . By relaxing this assumption to allow for multiple sequencing errors, we find the largest region consistent with IBD is 704 kb, which is approximately 1.5 centiMorgans (cM) 25 ( Figure 3) . If the two probands were as distantly related as fourth cousins, the expected IBD segment size would be 20 cM (conditioned on ascertainment from the presence of a shared variant). 26 Therefore, the variation between the two probands in this region is inconsistent with recent shared ancestry. If the two probands inherited the mutation from a more distant founder and if they share the entire 700 kb region, the estimated time to the founder would be around 3300 years ago. Because this variant is an X-linked recessive lethal mutation, the probability of its being eliminated in each transmission is 1/3, and the variant is therefore highly unlikely to have occurred 3300 years ago. We conclude that the disease-causing variant in the two families resulted from two independent mutational events.
Functional Analysis N-terminal acetylation of proteins is catalyzed by N-terminal acetyltransferases (NATs). The primary NAT in terms of targeted substrates is the evolutionarily conserved NatA. [27] [28] [29] The functional impact of N-terminal acetylation remains quite elusive, but recent data suggest a role as a destabilization signal for proteins. 30 The human NatA complex is composed of the catalytic subunit hNaa10p (hARD1) and the auxiliary subunit hNaa15p (NATH/hNAT1), both essential for its activity. 31 Increased
NatA levels have been linked to tumor progression, and 
depletion of NatA subunits from cancer cells induces cellcycle arrest and apoptosis. 32 Human Naa10p is a protein of 235 amino acid residues, of which the first 178 residues compose a globular region, whereas the latter 57 residues are predicted to form an unstructured and flexible C-terminal tail. 33 Thus, Ser37 is located in a structured part of hNaa10p. For many soluble globular proteins, Pro is known to be potentially disruptive for secondary structure elements such as the alpha-helix and beta-sheets. 34 Thus, although the structure of hNaa10p is undetermined, the p.Ser37Pro mutation could indeed affect the structure of hNaa10p and thereby the catalytic activity. Ser37 and its surrounding residues are highly conserved among eukaryotes, 31 suggesting an essential function. A SIFT analysis predicting whether an amino acid substitution affects protein function 35 strongly suggested that a substitution from Ser to Pro at position 37 would affect protein function with a score of 0.00. In order to directly assess the functional consequences of the hNaa10p p.Ser37Pro mutation, we analyzed the wildtype (WT) and the mutant proteins by a quantitative in vitro N-terminal acetylation assay. The enzyme activities of hNaa10p WT and hNaa10p p.Ser37Pro were determined with four unique peptides as substrate; these peptides having been previously shown to be acetylated by hNaa10p and NatA (Figure 4 ). Compared to hNaa10p WT, hNaa10p p.Ser37Pro displayed a 60%-80% reduction in NAT activity toward the in vivo substrate RNaseP protein p30 (AVFAD-) and toward b-actin (DDDIA-) and g-actin (EEEIA-). In contrast, the activity toward the NatA substrate high-mobility group protein A1 (SESSS-) was only reduced by 20% (Figure 4) . The oligopeptides AVFADand SESSS-represent classical cotranslational NatA substrates, being the N termini of proteins that are partially (AVFAD-) or fully (SESSS-) acetylated by NatA in HeLa cells. 27 On the other hand, b-actin (DDDIA-) and g-actin (EEEIA-) are nonclassical substrates recently shown to be acetylated more efficiently by hNaa10p/NatA than the classical substrates were, representing a posttranslational NAT activity. 36 
Discussion
The data presented here show that a mutation in an enzyme involved in N-terminal acetylation of proteins leads to a distinct, previously undescribed X-linked phenotype in humans and that males who carry the hypomorphic hNaa10p p.Ser37Pro allele die in infancy with cardiac arrhythmias. N-terminal acetylation is one of the most common protein modifications in humans, occurring on approximately 80% of all human proteins 27 It is catalyzed by several distinct NAT enzymes, of which the major one is NatA. 29 The catalytic subunit of the NatA complex, hNaa10p, is essential for survival in the organisms Drosophila melanogaster, 37 Trypanosoma brucei, 38 and Caenorhabditis elegans. 39 It is presumed that an amorphic NAA10 mutation would lead to embryonal lethality in humans, although one can only prove this by analyzing tissues from pregnancies that did not survive to term. The strong conservation of Naa10p Ser37, the predicted functional effect of p.Ser37Pro due to structural distortion, and the demonstrated disruption of catalytic activity by p.Ser37Pro (Figure 4 ) strongly imply that the hemizygous males with hNaa10p p.Ser37Pro have impaired NatA function. Thus, a variety of protein N termini, both those that are cotranslationally and those that are posttranslationally acetylated (e.g., actins), are likely to be insufficiently acetylated. Most likely, the serious consequences of the p.Ser37Pro mutation are caused by the lack of N-terminal acetylation for one or several proteins strictly requiring this modification for function or for maintenance of adequate amounts in the cell. Because hNaa10p has also been suggested to perform N-lysine (N-epsilon) acetylation of proteins such as beta-catenin, 40 a lack of N-lysine acetylation of selected substrates could also cause the observed effects. Finally, proposed noncatalytic functions of hNaa10p 41, 42 could be affected in the p.Ser37Pro mutant and thereby also play a role in the observed phenotypes. We have demonstrated herein that a probabilistic disease-causing variant discovery algorithm can readily identify and characterize the genetic basis of a previously unrecognized X-linked syndrome. We have also shown that this algorithm, when used in parallel with highthroughput sequencing, can identify variants with high prioritization for causing disease with as few as two individuals. In this instance, we screened~150 variants distributed among~2000 transcripts on the X chromosome in one sample from individual III-4 in family 1. With no prior filtering, we prioritized three to five possible candidate genes, and the mutation in NAA10 ranked second overall (Table 4) . Including exon capture data from relatives Informative SNVs consist of two classes: rare SNVs present in the proband from family 1 in genomic regions with high coverage in the second family, and common SNVs present in the first proband and at least one member of the second family. Variant c.109T>C is indicated by the triangle. We imputed the genotype of the proband from family 2 from the genotypes of the mother and unaffected sibling of the second family (see Table 7 ). SNVs inconsistent with IBD, in which the imputed genotype of the second proband does not match the first proband, are indicated with an X. After allowing for multiple sequencing errors, the largest genomic segment consistent with IBD is around 700 kb in length.
increased NAA10's ranking to first overall in just one family. Furthermore, after combining variants from the proband in family 1 with the obligate carrier mother in family 2, VAAST identified NAA10 as the only statistically significant candidate.
Although we have noted that the affected infants have an aged appearance, we have not established any direct link with progeria or other progeroid syndromes. The autopsies did not reveal any premature arteriosclerosis or degeneration of vascular smooth muscle cells, as is seen in Hutchinson-Gilford progeria syndrome (MIM 176670). 43, 44 Cell lines now being derived from family 1 and possibly future animal models will provide important insights about the pathophysiology underlying this previously unrecognized syndrome.
Supplemental Data
Supplemental Data include six figures and two tables and can be found with this article online at http://www.cell.com/AJHG/. Aliquots were collected at indicated time points and the acetylation reactions were quantified with reverse phase HPLC peptide separation. Error bars indicate the standard deviation based on three independent experiments. The five first amino acids in the peptides are indicated, for further details see Subjects and Methods. Time-dependent acetylation reactions were performed to determine initial velocity conditions when comparing the WT and Ser37Pro NAT activities toward different oligopeptides.
(C) Purified MBP-hNaa10p WT or p.Ser37Pro were mixed with the indicated oligopeptide substrates (200 mM for SESSS and AVFAD and 250 mM for DDDIA and EEEIA) and saturated levels of acetyl-CoA (400 mM) and incubated for 15 min (DDDIA and EEEIA) or 20 min (SESSS and AVFAD) at 37 C in acetylation buffer. The acetylation activity was determined as above. Error bars indicate the standard deviation based on three independent experiments. Black bars indicate the acetylation capacity of the MBP-hNaa10p WT, whereas white bars indicate the acetylation capacity of the MBP-hNaa10p mutant p.Ser37Pro. The five first amino acids in the peptides are indicated.
